SEC Company Response from Autolus Therapeutics plc (AUTL) (CIK 0001730463) (AUTL) — Jun 19, 2018
Autolus Therapeutics plc (AUTL) (CIK 0001730463)
Date: June 19, 2018 · CIK: 0001730463 · Accession: 0001193125-18-196928
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-224720
Letter
Forest House
58 Wood Lane
White City
London W12 7RZ
United Kingdom
VIA EDGAR
June 19, 2018
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Ms. Mary Beth Breslin
Ms. Irene Paik
Mr. Mark Brunhofer
Ms. Mary Mast
Re:
Autolus Therapeutics plc
Registration Statement on Form F-1
File No. 333-224720
Acceleration Request
Requested Date: Thursday, June 21, 2018
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-1 to become effective on June 21, 2018, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as its counsel may orally request via telephone call to the staff. The Registrant hereby authorizes each of Darren K. DeStefano and Courtney Thorne of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Darren K. DeStefano of Cooley LLP at + 1 703 456 8034, or in his absence, Courtney Thorne at + 1 617 937 2318. Thank you for your assistance with this matter.
[Signature Page Follows]
Sincerely,
AUTOLUS THERAPEUTICS PLC
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Forest House
58 Wood Lane
White City
London W12 7RZ
United Kingdom
VIA EDGAR
June 19, 2018
U.S.
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Ms. Mary Beth Breslin
Ms. Irene Paik
Mr. Mark Brunhofer
Ms. Mary Mast
Re:
Autolus Therapeutics plc
Registration Statement on Form F-1
File No. 333-224720
Acceleration Request
Requested Date: Thursday, June 21, 2018
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”)
hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-1 to
become effective on June 21, 2018, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as its counsel may orally request via telephone call to the staff. The Registrant hereby authorizes each of Darren K.
DeStefano and Courtney Thorne of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration
Statement has been declared effective, please orally confirm that event with Darren K. DeStefano of Cooley LLP at + 1 703 456 8034, or in his absence, Courtney Thorne at + 1 617 937 2318. Thank you for your assistance with this
matter.
[Signature Page Follows]
Sincerely,
AUTOLUS THERAPEUTICS PLC
By:
/s/ Christian Itin
Christian Itin
Chief Executive Officer
cc:
Matthias Alder, Autolus Therapeutics plc
Darren DeStefano, Cooley LLP
Christian Plaza, Cooley LLP
Brian
Leaf, Cooley LLP
Courtney Thorne, Cooley LLP
Katie Kazem, Cooley LLP